Pri-Med Washington, D.C | March 2026

Wednesday−Thursday, March 18–19|Washington, DC

Pri-Med Washington, D.C. | Medical Conference

Andrew E. Budson, MD
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Stephen N. Henry, DO, MS
Peter Lin, MD, CCFP
Vani Potluri, MD
Jeffrey Rado, MD, MPH, FAPA

Learn More

Wednesday, March 18 3:45–4:30pm

Beyond SSRIs: Treating Complicated Depression

Athica Vatanapradith, MD, DABOM
Charles Vega, MD, FAAFP

Earn CME/CE credits in Washington, D.C.

Register Now

Financial Disclosures

Andrew E. Budson, MD
Advisor: AbbVie; Speaker: Eli Lilly; Researcher: Vox Neuro, Eisai
Amy Clouse, MD, FAAFP
Stock Holder (publicly traded company): Eli Lilly and Novo Nordisk Inc.
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Consultant: OptumRx
Stephen N. Henry, DO, MS
No relevant financial relationships disclosed.
Peter Lin, MD, CCFP
Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Sanofi
Vani Potluri, MD
No relevant financial relationships disclosed.
Jeffrey Rado, MD, MPH, FAPA
Speaker: Alkermes; Researcher: Cerevel, Neurorelief, NRX Pharmaceuticals; Consultant: Paraxel
Athica Vatanapradith, MD, DABOM
Speaker: Inspire
Charles Vega, MD, FAAFP
Consultant: GlaxoSmithKline, Boehringer Ingelheim, Exact Sciences

Other Disclosures

Pamela Kushner, MD, FAAFP (Reviewer): Speaker and Advisor for GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Haleon, Corcept; Speaker for Phathom, Janssen; Advisor for Bausch/Salix, Bayer, Verdiva, Abbott

All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.